These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 29993327)

  • 1. Reports of lower respiratory tract infection following dose 1 of RotaTeq and Rotarix vaccines to the Vaccine Adverse Event Reporting System (VAERS), 2008-2016.
    Haber P; Amin M; Ng C; Weintraub E; McNeil MM
    Hum Vaccin Immunother; 2018; 14(11):2755-2759. PubMed ID: 29993327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety profile of rotavirus vaccines among individuals aged ≥8 months of age, United States, vaccine adverse event reporting system (VAERS), 2006-2019.
    Haber P; Tate J; Marquez PL; Moro PL; Parashar U
    Vaccine; 2021 Jan; 39(4):746-750. PubMed ID: 33267969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intussusception after monovalent rotavirus vaccine-United States, Vaccine Adverse Event Reporting System (VAERS), 2008-2014.
    Haber P; Parashar UD; Haber M; DeStefano F
    Vaccine; 2015 Sep; 33(38):4873-7. PubMed ID: 26276687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intussusception after rotavirus vaccines reported to US VAERS, 2006-2012.
    Haber P; Patel M; Pan Y; Baggs J; Haber M; Museru O; Yue X; Lewis P; Destefano F; Parashar UD
    Pediatrics; 2013 Jun; 131(6):1042-9. PubMed ID: 23669521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccines for preventing rotavirus diarrhoea: vaccines in use.
    Soares-Weiser K; Bergman H; Henschke N; Pitan F; Cunliffe N
    Cochrane Database Syst Rev; 2019 Oct; 2019(10):. PubMed ID: 31684685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccines for preventing rotavirus diarrhoea: vaccines in use.
    Soares-Weiser K; Bergman H; Henschke N; Pitan F; Cunliffe N
    Cochrane Database Syst Rev; 2019 Mar; 3(3):CD008521. PubMed ID: 30912133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccines for preventing rotavirus diarrhoea: vaccines in use.
    Soares-Weiser K; Maclehose H; Bergman H; Ben-Aharon I; Nagpal S; Goldberg E; Pitan F; Cunliffe N
    Cochrane Database Syst Rev; 2012 Nov; 11():CD008521. PubMed ID: 23152260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccines for preventing rotavirus diarrhoea: vaccines in use.
    Soares-Weiser K; Maclehose H; Bergman H; Ben-Aharon I; Nagpal S; Goldberg E; Pitan F; Cunliffe N
    Cochrane Database Syst Rev; 2012 Feb; (2):CD008521. PubMed ID: 22336845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term Consistency in Rotavirus Vaccine Protection: RV5 and RV1 Vaccine Effectiveness in US Children, 2012-2013.
    Payne DC; Selvarangan R; Azimi PH; Boom JA; Englund JA; Staat MA; Halasa NB; Weinberg GA; Szilagyi PG; Chappell J; McNeal M; Klein EJ; Sahni LC; Johnston SH; Harrison CJ; Baker CJ; Bernstein DI; Moffatt ME; Tate JE; Mijatovic-Rustempasic S; Esona MD; Wikswo ME; Curns AT; Sulemana I; Bowen MD; Gentsch JR; Parashar UD
    Clin Infect Dis; 2015 Dec; 61(12):1792-9. PubMed ID: 26449565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS)--United States, 1991-2001.
    Zhou W; Pool V; Iskander JK; English-Bullard R; Ball R; Wise RP; Haber P; Pless RP; Mootrey G; Ellenberg SS; Braun MM; Chen RT
    MMWR Surveill Summ; 2003 Jan; 52(1):1-24. PubMed ID: 12825543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Rotavirus Vaccination With Inpatient and Emergency Department Visits Among Children Seeking Care for Acute Gastroenteritis, 2010-2016.
    Payne DC; Englund JA; Weinberg GA; Halasa NB; Boom JA; Staat MA; Selvarangan R; Azimi PH; Klein EJ; Szilagyi PG; Chappell J; Sahni LC; McNeal M; Harrison CJ; Moffatt ME; Johnston SH; Mijatovic-Rustempasic S; Esona MD; Tate JE; Curns AT; Wikswo ME; Sulemana I; Bowen MD; Parashar UD
    JAMA Netw Open; 2019 Sep; 2(9):e1912242. PubMed ID: 31560386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Head-to-head comparison of the immunogenicity of RotaTeq and Rotarix rotavirus vaccines and factors associated with seroresponse in infants in Bangladesh: a randomised, controlled, open-label, parallel, phase 4 trial.
    Velasquez-Portocarrero DE; Wang X; Cortese MM; Snider CJ; Anand A; Costantini VP; Yunus M; Aziz AB; Haque W; Parashar U; Sisay Z; Soeters HM; Hyde TB; Jiang B; Zaman K
    Lancet Infect Dis; 2022 Nov; 22(11):1606-1616. PubMed ID: 35961362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Notes from the field: rotavirus vaccine administration errors--United States, 2006-2013.
    Hibbs BF; Miller ER; Shimabukuro T;
    MMWR Morb Mortal Wkly Rep; 2014 Jan; 63(4):81. PubMed ID: 24476980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The temporal relationship between RotaTeq immunization and intussusception adverse events in the Vaccine Adverse Event Reporting System (VAERS).
    Geier DA; King PG; Sykes LK; Geier MR
    Med Sci Monit; 2012 Feb; 18(2):PH12-17. PubMed ID: 22293889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Review of global rotavirus strain prevalence data from six years post vaccine licensure surveillance: is there evidence of strain selection from vaccine pressure?
    Dóró R; László B; Martella V; Leshem E; Gentsch J; Parashar U; Bányai K
    Infect Genet Evol; 2014 Dec; 28():446-61. PubMed ID: 25224179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surveillance for poliovirus vaccine adverse events, 1991 to 1998: impact of a sequential vaccination schedule of inactivated poliovirus vaccine followed by oral poliovirus vaccine.
    Wattigney WA; Mootrey GT; Braun MM; Chen RT
    Pediatrics; 2001 May; 107(5):E83. PubMed ID: 11331733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post-licensure surveillance of 13-valent pneumococcal conjugate vaccine (PCV13) in adults aged ⩾19years old in the United States, Vaccine Adverse Event Reporting System (VAERS), June 1, 2012-December 31, 2015.
    Haber P; Arana J; Pilishvili T; Lewis P; Moro PL; Cano M
    Vaccine; 2016 Dec; 34(50):6330-6334. PubMed ID: 27836437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An analysis of rotavirus vaccine reports to the vaccine adverse event reporting system: more than intussusception alone?
    Haber P; Chen RT; Zanardi LR; Mootrey GT; English R; Braun MM;
    Pediatrics; 2004 Apr; 113(4):e353-9. PubMed ID: 15060267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety monitoring in the Vaccine Adverse Event Reporting System (VAERS).
    Shimabukuro TT; Nguyen M; Martin D; DeStefano F
    Vaccine; 2015 Aug; 33(36):4398-405. PubMed ID: 26209838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of pentavalent and monovalent rotavirus vaccines in concurrent use among US children <5 years of age, 2009-2011.
    Payne DC; Boom JA; Staat MA; Edwards KM; Szilagyi PG; Klein EJ; Selvarangan R; Azimi PH; Harrison C; Moffatt M; Johnston SH; Sahni LC; Baker CJ; Rench MA; Donauer S; McNeal M; Chappell J; Weinberg GA; Tasslimi A; Tate JE; Wikswo M; Curns AT; Sulemana I; Mijatovic-Rustempasic S; Esona MD; Bowen MD; Gentsch JR; Parashar UD
    Clin Infect Dis; 2013 Jul; 57(1):13-20. PubMed ID: 23487388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.